Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $32,728,288.70
- Oct. 15, 2024
- Blake Borgeson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 5, 2023 | CEO | 13,327 | $6.46 | Sell | $86,092.42 | |
April 4, 2023 | Director | 8,885 | $6.53 | Sell | $58,019.05 | |
March 21, 2023 | Director | 8,885 | $7.40 | Sell | $65,749.00 | |
March 8, 2023 | CEO | 70,890 | $8.10 | Sell | $574,209.00 | |
March 7, 2023 | Director | 8,885 | $8.33 | Sell | $74,012.05 | |
March 2, 2023 | CEO | 18,500 | $7.92 | Sell | $146,520.00 | |
Feb. 27, 2023 | Major Shareholder | 52,500 | $7.69 | Buy | $403,725.00 | |
Feb. 23, 2023 | COO | 8,000 | $7.82 | Sell | $62,560.00 | |
Feb. 23, 2023 | Major Shareholder | 51,864 | $7.79 | Buy | $404,020.56 | |
Feb. 21, 2023 | Director | 8,885 | $7.73 | Sell | $68,681.05 | |
Feb. 21, 2023 | Major Shareholder | 94,418 | $7.74 | Buy | $730,795.32 | |
Feb. 16, 2023 | Major Shareholder | 42,682 | $7.90 | Buy | $337,187.80 | |
Feb. 15, 2023 | Insider | 7,486 | $8.33 | Sell | $62,358.38 | |
Feb. 14, 2023 | Major Shareholder | 6,300 | $7.95 | Buy | $50,085.00 | |
Feb. 10, 2023 | Major Shareholder | 11,000 | $7.98 | Buy | $87,780.00 | |
Feb. 7, 2023 | Director | 8,885 | $8.81 | Sell | $78,276.85 | |
Jan. 26, 2023 | COO | 8,000 | $8.07 | Sell | $64,560.00 | |
Jan. 25, 2023 | Major Shareholder | 24,526 | $7.88 | Buy | $193,264.88 | |
Jan. 24, 2023 | Director | 8,885 | $8.71 | Sell | $77,388.35 | |
Jan. 17, 2023 | Insider | 10,000 | $9.16 | Sell | $91,600.00 | |
Jan. 10, 2023 | Director | 8,885 | $7.69 | Sell | $68,325.65 | |
Jan. 9, 2023 | Major Shareholder | 76,046 | $7.64 | Buy | $580,991.44 | |
Jan. 5, 2023 | CEO | 18,500 | $7.39 | Sell | $136,715.00 | |
Dec. 29, 2022 | COO | 8,000 | $7.70 | Sell | $61,600.00 | |
Dec. 27, 2022 | Director | 8,885 | $7.25 | Sell | $64,416.25 | |
Dec. 15, 2022 | Insider | 10,000 | $8.85 | Sell | $88,500.00 | |
Dec. 13, 2022 | Director | 8,885 | $8.96 | Sell | $79,609.60 | |
Dec. 1, 2022 | CEO | 37,210 | $9.02 | Sell | $335,634.20 | |
Nov. 29, 2022 | Director | 8,885 | $8.75 | Sell | $77,743.75 | |
Nov. 17, 2022 | COO | 16,000 | $10.96 | Sell | $175,360.00 | |
Nov. 16, 2022 | Director | 17,770 | $11.12 | Sell | $197,602.40 | |
Nov. 15, 2022 | Insider | 10,000 | $12.31 | Sell | $123,100.00 | |
Nov. 3, 2022 | CEO | 36,693 | $10.00 | Sell | $366,930.00 | |
Oct. 27, 2022 | COO | 16,000 | $10.72 | Sell | $171,520.00 | |
Oct. 14, 2022 | Insider | 10,000 | $10.92 | Sell | $109,200.00 | |
Oct. 6, 2022 | CEO | 36,053 | $11.58 | Sell | $417,493.74 | |
Sept. 29, 2022 | COO | 16,000 | $10.86 | Sell | $173,760.00 | |
Sept. 15, 2022 | Insider | 10,000 | $13.36 | Sell | $133,600.00 | |
Aug. 16, 2022 | Insider | 30,000 | $12.61 | Sell | $378,300.00 | |
Aug. 16, 2022 | COO | 16,000 | $12.60 | Sell | $201,600.00 | |
Aug. 4, 2022 | CEO | 36,825 | $9.49 | Sell | $349,469.25 | |
July 7, 2022 | Chief Executive Officer | 18,500 | $0.00 | Buy | $0.00 | |
July 7, 2022 | Chief Executive Officer | 18,614 | $9.04 | Sell | $168,270.56 | |
July 7, 2022 | CEO | 37,114 | $9.05 | Sell | $335,881.70 | |
June 2, 2022 | CEO | 39,690 | $6.09 | Sell | $241,712.10 | |
May 4, 2022 | CEO | 31,830 | $6.49 | Sell | $206,576.70 | |
April 28, 2022 | CEO | 37,605 | $6.09 | Sell | $229,014.45 | |
April 21, 2022 | CEO | 37,155 | $6.31 | Sell | $234,448.05 | |
April 18, 2022 | CEO | 35,836 | $6.84 | Sell | $245,118.24 | |
April 14, 2022 | CEO | 34,517 | $7.56 | Sell | $260,948.52 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Shafique Virani, Michael Secora, Mubadala Investment Co Pjsc, Tina Marriott, Dean Y Li, Gibson Christopher, Terry-Ann Burrell, and Zavain Dar
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 51 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Oct. 15, 2024.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.